Table 3.

Proportions of prostate cancer detected and undetected by mpMRI in PROMIS, according to Gleason grade group.

GGG	MRI-detected PCa	MRI-undetected PCa	Difference
Group 1	5.9% (17/287)	14% (6/44)	8.1% (95% CI 0.02–16%)
Group 2	75% (214/287)	86% (38/44)	11% (95% CI –2.5% to 24%)
Group 3	15% (44/287)	0% (0/44)	–
Group 4	0.35% (1/287)	0% (0/44)	–
Group 5	3.8% (11/287)	0% (0/44)	–

CI = confidence interval; GGG = Gleason Ggrade Group; mpMRI = multiparametric MRI; MRI = magnetic resonance imaging; PCa = prostate cancer; PROMIS = Prostate Magnetic Resonance Imaging Study; TPM = template mapping.

Pathological results are from TPM biopsy.